The prevalence and impact of arthritis and other rheumatic conditions in the Uni... (t might not apply to the current U.S. po...)

(Date:5/16/2008).../PRNewswire/ -- ExamForce announced today the,hiri...rnment Sales Manager.,Mongeon formerly headed up t...s where he oversaw government sales and marketing ...op security certifications in the IT,industry., M...y left (ISC)2,Americas to spend more time with his...

(Date:5/16/2008)...s:, - 2007 Comprehensive Income increased 42% to ....9 million, - 2007 Gross Margin of 76%, - Produc...% to $12.2 million from $2.4 million as of Dece...Newswire-FirstCall/ -- Huiheng,Medical, Inc. ("Hui..., a,China-based leader in the development, sales a...

(Date:5/16/2008)... insulin-free for at least a year or two, , ...lanted islet cells help people with type 1 diabete...d appear to provide longer-term improved metabolic...ulin again, researchers report. , Using continu...he University of Miami Miller School of Medicine f...

(Date:5/16/2008)...6 /PRNewswire-USNewswire/ -- Karin Weisburgh,seni...fit publisher of,Consumer Reports magazine, was na...ar at CU,s Yonkers headquarters today., Ms. Weisb...ndles up in,the winter and rides in shirt sleeves ...along Quaker Ridge in New Rochelle, down Mill Road...

[0] ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts [0] Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 [1] Islet Cell Transplants Aid Type 1 Diabetics [0] Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year

...l the world is like a stage “, written by William ... of life? Good to read, nice to listen but a littl...lthough much importance has been given to aging, v...psychological and behavioral changes associated wi...

...eagues from Kyoto University Hospital has regenera...iac muscle cells were obtained from the heart tiss... the regenerated stem cells from humans into the h...le and blood vessels, the scientists found that th...

...taineers caught in avalanches and slipped in creva...ic in Nepal, has now offered to cope with a new em...the US. Freer left for Louisiana on Thursday, one ...owns with about one million displaced by the storm...

..., it leaves them maimed, paralysed and in a semi-c...of Japanese encephalitis as stark as in this forgo...as killed hundreds. "Encephalitis kills, but even ...completely normal life," admits Dr. K.P. Kushwaha ...

Other Medicine News:Health News:Do not regret growing older, It is a privilege denied to many 2 Health News:Encephalitis Survivors Face The Risk Of Becoming Disabled 2

Do not regret growing older, It is a privilege denied to many Therapeutic cloning by regenerating stem cells from heart muscles Lady Doctor from Nepal to Help Katrina victims Encephalitis Survivors Face The Risk Of Becoming Disabled

(Date:5/15/2008)...ts Confirm Efficacy for Population Most Affected b...May 16 /-,Bayer HealthCare ...c.,(Nasdaq: ONXX ) today announced that Nexavar(R...ll survival by 47.3 percent (HR=0.68;,p-value=0.01...anced,hepatocellular carcinoma (HCC), or primary l...

(Date:5/15/2008)...Efficacy Clinical Data from Prostate, Colorectal a..., - Company to Hold Investor Event on Sun., June ...alif., May 15 /- Poniard,Ph...eutical company focused,on oncology, today announc...linical trials of picoplatin, in various tumor typ...

(Date:5/15/2008)... reductions demonstrated in Blacks, Hispanics/Lati...se Individuals, PARSIPPANY, N.J., May 15 /PRNewsw... data presented at the American Society of,Hyperte...SH 2008) in New,Orleans demonstrated that the powe...esartan medoxomil) safely and effectively helped,p...

(Date:5/15/2008)...y 15 /- CenterWatch, a publishing and...search about clinical,trials, finds that investiga...ctronic data capture) systems. More than 75% of re... that they had been trained on three or more,EDC s... effectiveness of,their EDC training had improved....

Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7 CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2 Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 1 Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 2 Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers 26 Distribution Managers 9819 3 Cardiome And Astellas Announce Regulatory Update 9815 1 Cardiome And Astellas Announce Regulatory Update 9815 2 Cardiome And Astellas Announce Regulatory Update 9815 3 Cardiome And Astellas Announce Regulatory Update 9815 4 Study looks at off label use of biliary stents 9812 1 Study looks at off label use of biliary stents 9812 2 NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 1 NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 2 NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 3 NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 4 NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 5

[0] Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study [0] Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting [0] Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations [0] CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence

... - Study shows orally-delivered GLP-1 is able to s...9, 2007 /PRNewswire-FirstCall/ --,Emisphere Techno...l,studies conducted in collaboration with Professo...rology and Hepatology,University Hospital Basel i...ith glucagon-like peptide-1 (7-36 amide) (GLP-1) w...

... SAN DIEGO--(BUSINESS WIRE)--Mar 29, 2007 - ACADIA...eutical company utilizing,innovative technology to...ovel treatments for central nervous system,disorde...at the,2007 International Congress on Schizophreni...07, in Colorado Springs, Colorado.,Presentations w...

Other Medicine Technology:Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 2 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 3 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 4 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 5 ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 2 ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 3 ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 4 ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 5

Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research

...the flexibility of polyaxial screws and the versat... The result is a construct that, during assembly, ...my, thus reducing potential for vertebral injury. ...nnectors reduces the potential for transferring lo...

...chnology in spinal instrumentation to treat a vari...umbar spine, spondylolisthesis, kyphosis, scoliosi...he treaent of severe spondylolisthesis (grades 3 a...ew fixation for this indication are from L3-S1. Wh...

Multiwindow transcranial and peripheral doppler system.

Transcranial & peripheral vascular doppler system.

Medicine Products:

ST360 Spinal Fixation System Spine System Evolution Sonomed-300/E TC 22

The prevalence and impact of arthritis and other rheumatic conditions in the Uni...(t might not apply to the current U.S. po...),Health